Janice M. Mehnert - Concepedia

Author

Janice M. Mehnert

Rutgers Cancer Institute

Also Known As

J. M. Mehnert, J. Mehnert, J.M. Mehnert, Janice M. Mehnert, Janice Mehnert

Publications

570

Citations

H-Index

Concepts

All Affiliations

Rutgers Cancer Institute Rutgers, The State University of New Jersey Fred Hutch Cancer Center Yale Cancer Center Huntsman Cancer Institute

About

Janice M. Mehnert is an author at Rutgers Cancer Institute specializing in oncology, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	239
2	Immunology	2	2	124
3	Cell Biology	1	1	103
4	Pathology	1	1	12
5	Cancer Cell Biology	1	1	12

Janice M. Mehnert

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial Alain P. Algazi, Megan Othus, Adil Daud, Nature Medicine Tumor BiologyRandomized Phase 2MedicineMelanomaImmunology	2020	108
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays Janice M. Mehnert, Mary M. McCarthy, Lucia B. Jilaveanu, Human Pathology Quantitative ExpressionMedicineMelanomaMelanoma Tissue MicroarraysCancer Biology	2009	103
<i>BRAF</i> Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in <i>BRAF</i>V600E Mutant Melanoma Atul Kulkarni, Husam Al-hraishawi, Srilatha Simhadri, Clinical Cancer Research	2017	61
SWOG S1320: A randomized phase II trial of intermittent versus continuous dosing of dabrafenib and trametinib in BRAF<sup>V600E/k</sup> mutant melanoma. Alain P. Algazi, Megan Othus, Adil Daud, Journal of Clinical Oncology Swog S1320Cancer ManagementImmunologyImmunotherapeuticsDermatology	2015	16
VEGF, VEGFR1, and VEGFR2 expression in melanoma Janice M. Mehnert, Mary M. McCarthy, Salim Aziz, Journal of Clinical Oncology Tumor BiologyAngiogenesisOncologyMedicineMelanoma	2007	12
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, Journal for ImmunoTherapy of Cancer	2016	11
Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment George Jour, Irineu Illa-Bochaca, Milad Ibrahim, Journal of Investigative Dermatology	2022	11

Page 1